Level Four Advisory Services’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.17M | Sell |
15,946
-417
| -3% | -$155K | 0.17% | 158 |
|
|
2026
Q1 | $4.79M | Buy |
16,363
+5,173
| +46% | +$1.7M | 0.16% | 176 |
|
|
2025
Q4 | $3.92M | Sell |
11,190
-4,169
| -27% | -$1.41M | 0.13% | 202 |
|
|
2025
Q3 | $4.96M | Sell |
15,359
-1,588
| -9% | -$494K | 0.17% | 165 |
|
|
2025
Q2 | $6.59M | Buy |
16,947
+950
| +6% | +$382K | 0.24% | 113 |
|
|
2025
Q1 | $6.96M | Buy |
15,997
+5,187
| +48% | +$2.08M | 0.29% | 93 |
|
|
2024
Q4 | $3.99M | Sell |
10,810
-2,403
| -18% | -$1.01M | 0.16% | 164 |
|
|
2024
Q3 | $5.36M | Buy |
13,213
+1,428
| +12% | +$763K | 0.23% | 131 |
|
|
2024
Q2 | $6.39M | Buy |
11,785
+6,951
| +144% | +$3.67M | 0.29% | 89 |
|
|
2024
Q1 | $2.28M | Hold |
4,834
| – | – | 0.13% | 183 |
|
|
2023
Q4 | $2.28M | Sell |
4,834
-399
| -8% | -$185K | 0.13% | 181 |
|
|
2023
Q3 | $2.28M | Buy |
5,233
+2,697
| +106% | +$1.22M | 0.15% | 166 |
|
|
2023
Q2 | $1.13M | Buy |
2,536
+106
| +4% | +$48.9K | 0.07% | 268 |
|
|
2023
Q1 | $1.12M | Buy |
2,430
+824
| +51% | +$392K | 0.07% | 260 |
|
|
2022
Q4 | $824K | Buy |
1,606
+459
| +40% | +$233K | 0.06% | 285 |
|
|
2022
Q3 | $521K | Sell |
1,147
-2
| -0.2% | -$957 | 0.05% | 306 |
|
|
2022
Q2 | $554K | Buy |
1,149
+2
| +0.2% | +$989 | 0.05% | 314 |
|
|
2022
Q1 | $563K | Buy |
1,147
+112
| +11% | +$51.2K | 0.04% | 364 |
|
|
2021
Q4 | $480K | Sell |
1,035
-99
| -9% | -$41.6K | 0.04% | 399 |
|
|
2021
Q3 | $423K | Buy |
1,134
+175
| +18% | +$66.5K | 0.04% | 322 |
|
|
2021
Q2 | $366K | Sell |
959
-127
| -12% | -$48.5K | 0.03% | 486 |
|
|
2021
Q1 | $390K | Buy |
1,086
+91
| +9% | +$29.3K | 0.03% | 435 |
|
|
2020
Q4 | $319K | Sell |
995
-76
| -7% | -$23.3K | 0.03% | 453 |
|
|
2020
Q3 | $288K | Sell |
1,071
-486
| -31% | -$131K | 0.02% | 448 |
|
|
2020
Q2 | $409K | Buy |
1,557
+150
| +11% | +$40K | 0.03% | 404 |
|
|
2020
Q1 | $321K | Buy |
1,407
+94
| +7% | +$25.6K | 0.04% | 379 |
|
|
2019
Q4 | $397K | Buy |
1,313
+417
| +47% | +$115K | 0.02% | 414 |
|
|
2019
Q3 | $215K | Sell |
896
-127
| -12% | -$34.8K | 0.02% | 464 |
|
|
2019
Q2 | $289K | Buy |
1,023
+123
| +14% | +$33.6K | 0.03% | 430 |
|
|
2019
Q1 | $258K | Sell |
900
-41
| -4% | -$11.9K | 0.03% | 442 |
|
|
2018
Q4 | $247K | Buy |
941
+208
| +28% | +$57.2K | 0.03% | 438 |
|
|
2018
Q3 | $201K | Buy |
+733
| New | +$190K | 0.02% | 560 |
|
Other funds holding ELV
Level Four Advisory Services's ELV Position: Q2 2026 in Review
Level Four Advisory Services reduced its Elevance Health (ELV) stake by 2.5% in Q2 2026, selling an estimated $155K and leaving 15,946 shares worth $6.17M. The position accounts for 0.17% of the portfolio, ranked #158.
Level Four Advisory Services first reported a position in ELV in Q3 2018 and has held it in 32 quarters since. The position peaked at $6.96M in Q1 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Level Four Advisory Services held 15,946 shares of Elevance Health worth $6.17M as of Q2 2026.
- Level Four Advisory Services sold 417 Elevance Health shares in Q2 2026, an estimated $155K.
- Elevance Health made up 0.17% of Level Four Advisory Services's portfolio in Q2 2026, its #158 holding.
- Level Four Advisory Services first reported a position in Elevance Health in Q3 2018 and has held it in 32 quarters since.
- Level Four Advisory Services's Elevance Health position peaked at $6.96M in Q1 2025.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Level Four Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.